Skip to content

Frederick S. Barrett

Johns Hopkins University, Johns Hopkins Medicine

66 papers in the library · 7,620 citations · publishing 2015-2026

Papers

Sort Most recent Most cited

Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.

Journal of Contextual Behavioral Science 2020 Alan K. Davis, Frederick S. Barrett, Roland R. Griffiths 369 citations

Prior research has shown that acute subjective psychedelic effects are associated with both spontaneous and intended changes in depression and anxiety. Psychedelics are also theorized to produce increases in psychological flexibility, which could explain decreases in depression and anxiety following a psychedelic experience. Therefore, the present cross-sectional survey study sought to examine...

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Pharmacology & Therapeutics May 1, 2019 Matthew W Johnson, Peter S. Hendricks, Frederick S. Barrett et al. 520 citations

The purpose of this paper is to provide an integrative review and offer novel insights regarding human research with classic psychedelics (classic hallucinogens), which are serotonin 2A receptor (5-HT2AR) agonists such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Classic psychedelics have been administered as sacraments since ancient times. They were of prominent interest...

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

Psychopharmacology October 1, 2018 Frederick S. Barrett, Theresa M. Carbonaro, Ethan Hurwitz et al. 109 citations

Classic psychedelics (serotonin 2A receptor agonists) and dissociative hallucinogens (NMDA receptor antagonists), though differing in pharmacology, may share neuropsychological effects. These drugs, however, have undergone limited direct comparison. This report presents data from a double-blind, placebo-controlled within-subjects study comparing the neuropsychological effects of multiple doses...

DOI: 10.1007/s00213-018-4981-x (opens in new tab) Full text (opens in new tab) Mind-altering substance Psilocybin research Psilocybin studies Psychedelic drug psilocybin +17

Psychedelics and music: neuroscience and therapeutic implications

International Review of Psychiatry July 4, 2018 Frederick S. Barrett, Katrin H. Preller, Mendel Kaelen 85 citations

From the beginning of therapeutic research with psychedelics, music listening has been consistently used as a method to guide or support therapeutic experiences during the acute effects of psychedelic drugs. Recent findings point to the potential of music to support meaning-making, emotionality, and mental imagery after the administration of psychedelics, and suggest that music plays an...

“Hallucinations” Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs

Cannabis and Cannabinoid Research April 2, 2018 Muhammad Waqas, Frederick S. Barrett, Nicolas J. Schlienz et al. 37 citations

Introduction: Cannabis has been historically classified as a hallucinogen. However, subjective cannabis effects do not typically include hallucinogen-like effects. Empirical reports of hallucinogen-like effects produced by cannabis in controlled settings, particularly among healthy research volunteers, are rare and have mostly occurred after administration of purified Δ-9 tetrahydrocannabinol...

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

Current Topics in Behavioral Neurosciences 2018 Frederick S. Barrett, Roland R. Griffiths 268 citations

This chapter begins with a brief review of descriptions and definitions of mystical-type experiences and the historical connection between classic hallucinogens and mystical experiences. The chapter then explores the empirical literature on experiences with classic hallucinogens in which claims about mystical or religious experiences have been made. A psychometrically validated questionnaire is...

DOI: 10.1007/7854_2017_474 (opens in new tab) Full text (opens in new tab) These substances Specific compounds Substance use Mystical states +8

Neuroticism is associated with challenging experiences with psilocybin mushrooms.

Personality and Individual Differences October 15, 2017 Frederick S. Barrett, Matthew W Johnson, Roland R. Griffiths 98 citations

Classic hallucinogens (e.g. psilocybin and LSD) have substantial effects on perception, cognition, and emotion that can often be psychologically challenging, however we know very little regarding the source of significant individual variability that has been observed in the frequency and intensity of challenging experiences (i.e. "bad trips") with psychedelics. Previous clinical and...

DOI: 10.1016/j.paid.2017.06.004 (opens in new tab) Full text (opens in new tab) Bad trips Challenging experiences Individual differences Neuroticism +1

Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Journal of Psychopharmacology October 11, 2017 Roland R. Griffiths, Matthew W. Johnson, William A. Richards et al. 528 citations

Psilocybin can occasion mystical-type experiences with participant-attributed increases in well-being. However, little research has examined enduring changes in traits. This study administered psilocybin to participants who undertook a program of meditation/spiritual practices. Healthy participants were randomized to three groups (25 each): (1) very low-dose (1 mg/70 kg on sessions 1 and 2)...

Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music

Cerebral Cortex September 12, 2017 Frederick S. Barrett, Katrin H. Preller, Marcus Herdener et al. 52 citations

Abstract Classic psychedelic drugs (serotonin 2A, or 5HT2A, receptor agonists) have notable effects on music listening. In the current report, blood oxygen level-dependent (BOLD) signal was collected during music listening in 25 healthy adults after administration of placebo, lysergic acid diethylamide (LSD), and LSD pretreated with the 5HT2A antagonist ketanserin, to investigate the role of...

Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions

Frontiers in Psychology July 25, 2017 Hollis Robbins, David Smooke, Frederick S. Barrett et al. 62 citations

Psilocybin is a classic (serotonergic) hallucinogen ("psychedelic" drug) that may occasion mystical experiences (characterized by a profound feeling of oneness or unity) during acute effects. Such experiences may have therapeutic value. Research and clinical applications of psychedelics usually include music listening during acute drug effects, based on the expectation that music will provide...

DOI: 10.3389/fpsyg.2017.01238 (opens in new tab) Mysticism Music therapy Psychotherapist Applied psychology +2

Effects of LSD on music-evoked brain activity

bioRxiv (Cold Spring Harbor Laboratory) June 25, 2017 Mendel Kaelen, Romy Lorenz, Frederick S. Barrett et al. 20 citations preprint

Abstract Music is a highly dynamic stimulus, and consists of distinct acoustic features, such as pitch, rhythm and timbre. Neuroimaging studies highlight a hierarchy of brain networks involved in music perception. Psychedelic drugs such as lysergic acid diethylamide (LSD) temporary disintegrate the normal hierarchy of brain functioning, and produce profound subjective effects, including...

DOI: 10.1101/153031 (opens in new tab) Full text (opens in new tab) Active listening Sound perception Music psychology Cognitive psychology +5

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

Journal of Psychopharmacology November 18, 2016 Frederick S. Barrett, Matthew P. Bradstreet, Jeannie‐marie Leoutsakos et al. 364 citations

Acute adverse psychological reactions to classic hallucinogens (“bad trips” or “challenging experiences”), while usually benign with proper screening, preparation, and support in controlled settings, remain a safety concern in uncontrolled settings (such as illicit use contexts). Anecdotal and case reports suggest potential adverse acute symptoms including affective (panic, depressed mood),...

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences

Journal of Psychopharmacology August 31, 2016 Theresa M. Carbonaro, Matthew P. Bradstreet, Frederick S. Barrett et al. 541 citations

Acute and enduring adverse effects of psilocybin have been reported anecdotally, but have not been well characterized. For this study, 1993 individuals (mean age 30 yrs; 78% male) completed an online survey about their single most psychologically difficult or challenging experience (worst “bad trip”) after consuming psilocybin mushrooms. Thirty-nine percent rated it among the top five most...

LSD modulates music-induced imagery via changes in parahippocampal connectivity.

European Neuropsychopharmacology April 12, 2016 Mendel Kaelen, Leor Roseman, Joshua Kahan et al. 143 citations

Psychedelic drugs such as lysergic acid diethylamide (LSD) were used extensively in psychiatry in the past and their therapeutic potential is beginning to be re-examined today. Psychedelic psychotherapy typically involves a patient lying with their eyes-closed during peak drug effects, while listening to music and being supervised by trained psychotherapists. In this context, music is...

Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

Journal of Psychopharmacology October 6, 2015 Frederick S. Barrett, Matthew W Johnson, Roland R. Griffiths 634 citations

The 30-item revised Mystical Experience Questionnaire (MEQ30) was previously developed within an online survey of mystical-type experiences occasioned by psilocybin-containing mushrooms. The rated experiences occurred on average eight years before completion of the questionnaire. The current paper validates the MEQ30 using data from experimental studies with controlled doses of psilocybin. Data...

DOI: 10.1177/0269881115609019 (opens in new tab) Psilocybin Mysticism Structural equation modeling Hallucinogen +2

LSD enhances the emotional response to music.

Psychopharmacology October 2015 Mendel Kaelen, Frederick S. Barrett, Leor Roseman et al.

There is renewed interest in the therapeutic potential of psychedelic drugs such as lysergic acid diethylamide (LSD). LSD was used extensively in the 1950s and 1960s as an adjunct in psychotherapy, reportedly enhancing emotionality. Music is an effective tool to evoke and study emotion and is considered an important element in psychedelic-assisted psychotherapy; however, the hypothesis that...